-
A648709-100mgAZD6280 is a novel, subtype-selective GABAAα2/3 receptor positive modulators, used for treatment of generalized anxiety disorder.
-
-
-
A607858-50mgAZD-1678 is a potent CCR4 receptor antagonist.
-
A607858-10mgAZD-1678 is a potent CCR4 receptor antagonist.
-
A607847-50mgAzalanstat is a lanosterol 14 alpha-demethylase inhibitor. The enzyme catalyzes the first step in the conversion of lanosterol to cholesterol in mammals.
-
A607847-25mgAzalanstat is a lanosterol 14 alpha-demethylase inhibitor. The enzyme catalyzes the first step in the conversion of lanosterol to cholesterol in mammals.
-
A607847-10mgAzalanstat is a lanosterol 14 alpha-demethylase inhibitor. The enzyme catalyzes the first step in the conversion of lanosterol to cholesterol in mammals.
-
A607772-50mgASN04421891 is a potent GPR17 receptor modulator, with an EC 50 of 3.67 nM in [35S]GTPγS binding assay. ASN04421891 is promising to be used for neurodegenerative diseases research.
-
A607597-50mgAmelubant (BIIL 284) is a potent and long acting LTB4 receptor antagonist, negligibly binds to LTB4 receptor, with Kis of 221 nM and 230 nM in vital cells and membranes. Amelubant (BIIL 284) is a proagent of active metabolites BIIL 260 and BIIL 315.
-
A607597-10mgAmelubant (BIIL 284) is a potent and long acting LTB4 receptor antagonist, negligibly binds to LTB4 receptor, with Kis of 221 nM and 230 nM in vital cells and membranes. Amelubant (BIIL 284) is a proagent of active metabolites BIIL 260 and BIIL 315.
-